Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 01:31:36 27/04/2024 am IST Pre-market 06:52:00 pm
25.4 USD +0.55% Intraday chart for Pfizer, Inc. 25.48 +0.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Big tech saves the day, again Our Logo
CAC40: France's rating maintained = non-event CF
Earnings, Tech Outlooks Lift Wall Street Pre-Bell; Asia, Europe Up MT
CAC40: starts the week slightly up, crosses the 8100 mark CF
CAC 40: cautious rise ahead of a busy week CF
S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon MT
Pfizer Gets FDA Approval for Bleeding Disorder Treatment MT
Sector Update: Health Care Stocks Mixed Premarket Friday MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment MT
Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment MT
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B DJ
US FDA approves Pfizer's gene therapy for rare bleeding disorder RE
U.S. FDA Approves Pfizer Inc.'s Beqvez (Fidanacogene Elaparvovec-Dzkt), A One-Time Gene Therapy for Adults with Hemophilia B CI
Sector Update: Health Care Stocks Drop in Afternoon Trading MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines MT
GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines MT
GSK Files Lawsuit Against Pfizer, BioNTech Over mRNA Patents Infringement MT
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology RE
Bristol Myers posts quarterly loss, revenue rises 5% RE
Scholz promises support for pharma sector in Germany as Merck invests RE
Pfizer Keeps Q2 Dividend at $0.42 a Share, Payable June 14 to Holders of Record May 10 MT
Pfizer Inc. Declares Second-Quarter 2024 Dividend, Payable on June 14, 2024 CI
Edwards Lifesciences Corporation: The story continues Our Logo
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
25.4 USD
Average target price
31.62 USD
Spread / Average Target
+24.49%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Pfizer, BioNTech Receive European Medicines Agency Panel's Backing for Full Marketing Permit for COVID-19 Vaccine